Riskpilot← Back to searchSign inGet full accessEHEALTH2U AS
ASActiveOrg 817569102Rådhusgata 17, 0158 OsloKonsulentvirksomhet tilknyttet informasjonsteknologi · NACE 62020Est. 20160 employees
Revenue 2023
NOK 0
EBITDA margin
—
+11% vs 2022
Equity ratio
-3157.3%
Financial strength
Net profit 2023
NOK -21K
+11% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -21K | +11% |
| Net profit | NOK -21K | +11% |
| Total assets | NOK 2K | -49% |
| Equity | NOK -48K | -79% |
| Employees | 0 | — |
Legal name
EHEALTH2U AS
Org number
817569102
Legal form
Aksjeselskap
NACE code
62020 · Konsulentvirksomhet tilknyttet informasjonsteknologi
Founded
16. august 2016
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Rolv-erik spilling
Company purpose
Levere helserelaterte ikt/softwaretjenester/produkter, samt andre tjenester/produkter som faller naturlig sammen med dette, herunder å delta i andre selskaper med lignende virksomhet og kjøp og salg av aksjer.
Address
Rådhusgata 17, 0158 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −18 | −22 | −34 | −24 | −21 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −18 | −22 | −34 | −24 | −21 |
| Net financials | 0 | 0 | −1 | 0 | 0 |
| Profit before tax | −18 | −22 | −36 | −24 | −21 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −18 | −22 | −36 | −24 | −21 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 56 | 34 | 17 | 3 | 2 |
| Equity | 54 | 33 | −3 | −27 | −48 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 1 | 20 | 30 | 50 |
| Total debt | 1 | 1 | 20 | 30 | 50 |
EBITDA margin
-2146300.0%
This company
15.8%
Market median
-13584277% vs market
20192023
Equity ratio
-3157.3%
This company
38.2%
Market median
-8365% vs market
20192023
Return on equity
-2146300.0%
This company
18.4%
Market median
-11664774% vs market
20192023
Net profit margin
-2146300.0%
This company
8.1%
Market median
-26497631% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2016 | |
| Board of Directors | 2016 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2023 | |
| Company | 25% | 25% | 2023 | |
| Company | 25% | 25% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Eritreum As
EHEALTH2U AS Board members of EHEALTH2U AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stein Erik Moe | Board of Directors | 0 companies |
| Rolv-Erik Spilling | Board of Directors | 0 companies |
| Erik Kreyberg Normann | Chairman | 0 companies |
| Torgeir Hovden | Board of Directors | 0 companies |